Cure My Disease

Don't miss your cure!

 Log in / Sign up

Two-Year safety check for promising ALS pill

NCT ID NCT04577404

Completed Disease control Sponsor: Tanabe Pharma America, Inc. Source: ClinicalTrials.gov ↗

Summary

This study aimed to check the long-term safety of an oral medication called edaravone for people with ALS over two years. It was an extension study for 124 participants who had already completed a previous trial. The main goal was to monitor for any side effects or health problems that might occur during extended use of the drug.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Medical University Hospital

    Nagakute-shi, Aichi-ken, 480-1195, Japan

  • Alleghany General Hospital

    Pittsburgh, Pennsylvania, 15212, United States

  • CHU-Nice - Hopital Pasteur 2

    Nice, Cedex 1, 06001, France

  • Centre Hospitalier Esquirol

    Limoges, Marcland, 87025, France

  • Centre Hospitalier Universitaire (CHU) de Bordeaux

    Bordeaux, 33400, France

  • Deutsche Klinik fuer Diagnostik

    Wiesbaden, Hesse, 65191, Germany

  • Emory University - School of Medicine

    Atlanta, Georgia, 30317-2819, United States

  • Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)

    Milan, 20162, Italy

  • Fukushima Medical University Hospital

    Fukushima, Fukushima, 960-1295, Japan

  • Heritage Medical Research Clinic - University Of Calgary

    Calgary, Alberta, T2N 4Z6, Canada

  • Hopital Pierre Wertheimer - Hopital Neurologique

    Paris, 75013, France

  • Johns Hopkins University

    Baltimore, Maryland, 21209, United States

  • Juntendo University Hospital

    Bunkyo-ku, Tokyo, 113-8431, Japan

  • Kagawa University Hospital

    Kita-gun, Kagawa-ken, 761-0793, Japan

  • Kansai Electric Power Hospital Recruiting

    Fukushima-ku, Osaka-shi, Osaka, 553-0003, Japan

  • Kitasato University Hospital

    Sagamihara, Kanagawa, 252-0375, Japan

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, 30625, Germany

  • Montreal Neurological Institute and Hospital

    Montreal, Quebec, H3A 2B4, Canada

  • Murakami Karindoh Hospital

    Fukuoka, Fukuoka, 819-8585, Japan

  • National Hospital Organization Chibahigashi National Hospital

    Chiba, Chiba, 260-8712, Japan

  • National Hospital Organization Hokkaido Medical Center

    Sapporo, Hokkaido, 063-0005, Japan

  • National Hospital Organization Iou National Hospital

    Kanazawa, Ishikawa-ken, 920-0192, Japan

  • National Hospital Organization Kumamoto Saishun Medical Center

    Koshi-shi, Kumamoto, 861-1196, Japan

  • National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders

    Shizuoka, Shizuoka, 420-8688, Japan

  • National Hospital Organization Toneyama Medical Center

    Toyonaka-shi, Osaka, 560-8552, Japan

  • Neurology Associates, P.C - Lincoln

    Lincoln, Nebraska, 68506, United States

  • Neuromuscular Research Center

    Phoenix, Arizona, 85028, United States

  • Niigata University Medical And Dental Hospital

    Niigata, Niigata, 951-8520, Japan

  • Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)

    Milan, Lombardy, 20132, Italy

  • Penn State Hershey Children's Hospital

    Hershey, Pennsylvania, 17025, United States

  • Shiga University of Medical Science Hospital

    Ōtsu, Shiga, 520-2192, Japan

  • St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center

    Phoenix, Arizona, 85013, United States

  • Texas Neurology, PA

    Dallas, Texas, 75214, United States

  • Toho University Omori Medical Center

    Ōta-ku, Tokyo, 143-8541, Japan

  • Tohoku University Hospital

    Sendai, Miyagi, 980-8574, Japan

  • Tokyo Metropolitan Neurological Hospital

    Fuchū, Tokyo, 183-0042, Japan

  • UF Health Cancer Center

    Gainesville, Florida, 32610-3633, United States

  • Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA)

    Turin, Piedmont, 10126, Italy

  • University of Alberta - Walter C Mackenzie Health Sciences Centre (WCM)

    Edmonton, Alberta, T6G 2B7, Canada

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045, United States

  • Wake Forest University Baptist Medical Center (WFUBMC) - The J. Paul Sticht Center on Aging and Rehabilitation

    Winston-Salem, North Carolina, 27157, United States

  • Woodland Research Northwest

    Rogers, Arkansas, 72758, United States

  • Yokohama City University Hospital

    Yokohama, Kanagawa, 236-0004, Japan

Conditions

Explore the condition pages connected to this study.

AMYOTROPHIC LATERAL SCLEROSIS (ALS)